Heart-hand syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:228184
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Heart-hand syndrome (Orphanet code 228184) is a group of rare genetic disorders characterized by the co-occurrence of congenital heart defects and limb (particularly hand and forearm) abnormalities. This designation encompasses several distinct clinical entities in which cardiac and upper limb malformations present together, reflecting shared developmental pathways during embryogenesis. The most well-known subtypes include Holt-Oram syndrome (heart-hand syndrome type I), which is caused by mutations in the TBX5 gene, as well as other rarer forms. The cardiac manifestations typically include atrial and ventricular septal defects, conduction abnormalities (such as atrioventricular block), and other structural heart malformations. Upper limb anomalies range from subtle findings such as triphalangeal or absent thumbs to more severe defects including radial ray abnormalities, hypoplastic or absent radius, and phocomelia. The severity of both cardiac and limb involvement is highly variable, even within the same family. Diagnosis is typically made in the neonatal period or during childhood based on clinical findings, echocardiography, skeletal radiographs, and genetic testing. Management is multidisciplinary and depends on the specific manifestations present. Cardiac defects may require surgical repair or medical management of arrhythmias, while limb abnormalities may benefit from orthopedic interventions, occupational therapy, or reconstructive surgery. Genetic counseling is recommended for affected individuals and their families. There is currently no cure, and treatment remains supportive and symptom-directed.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2025Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Acibadem University — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Heart-hand syndrome.

View clinical trials →

No actively recruiting trials found for Heart-hand syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Heart-hand syndrome community →

Specialists

1 foundView all specialists →
BM
Bettina F Cuneo, MD
AURORA, CO
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Heart-hand syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Heart-hand syndromeForum →

No community posts yet. Be the first to share your experience with Heart-hand syndrome.

Start the conversation →

Latest news about Heart-hand syndrome

Disease timeline:

New recruiting trial: Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

A new clinical trial is recruiting patients for Heart-hand syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Heart-hand syndrome

What is Heart-hand syndrome?

Heart-hand syndrome (Orphanet code 228184) is a group of rare genetic disorders characterized by the co-occurrence of congenital heart defects and limb (particularly hand and forearm) abnormalities. This designation encompasses several distinct clinical entities in which cardiac and upper limb malformations present together, reflecting shared developmental pathways during embryogenesis. The most well-known subtypes include Holt-Oram syndrome (heart-hand syndrome type I), which is caused by mutations in the TBX5 gene, as well as other rarer forms. The cardiac manifestations typically include at

At what age does Heart-hand syndrome typically begin?

Typical onset of Heart-hand syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Heart-hand syndrome?

1 specialists and care centers treating Heart-hand syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.